Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,745,318 Fluorescent red emitting functionalizable calcium indicators
Compounds of formula I ##STR00001## and a process for manufacturing the compounds. A method of using the compounds for the detection of calcium ions and a...
US-9,745,317 Heterocyclic compounds and their use as dopamine D1 ligands
The present invention provides, in part, compounds of Formula (I): and pharmaceutically acceptable salts thereof; processes for the preparation of;...
US-9,745,316 Lactam kinase inhibitors
Compounds useful as kinase inhibitors are provided herein, as well as salts, pharmaceutical compositions, methods of medical treatment and methods of synthesis...
US-9,745,315 Crystals of dispiropyrrolidine derivatives
Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of Mdm2 are provided. The present invention provides crystals of ...
US-9,745,314 MDM2 inhibitors and therapeutic methods using the same
Inhibitors of MDM2 and MDM2-related proteins and compositions containing the same are disclosed. Methods of using the MDM2 inhibitors in the treatment of...
US-9,745,313 Macrocycles as factor XIa inhibitors
The present invention provides compounds of Formula (I): ##STR00001## or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, wherein all...
US-9,745,312 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation
Compounds are provided that act as potent antagonists of the CCR2 receptor. The compounds are generally aryl sulfonamide derivatives and are useful in...
US-9,745,311 Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
The present invention relates to pyrazine derivatives of Formula I, and pharmaceutical compositions including the same, that are inhibitors of one or more FGFR...
US-9,745,310 Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same
The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising...
US-9,745,309 Method for preparing a sitagliptin intermediate
The present invention provides a method for preparing an intermediate compound of sitagliptin represented by formula I. The preparation method comprises:...
US-9,745,308 Pyridazinone derivatives as phoshoinositide 3-kinases inhibitors
Compounds of formula (I) described herein inhibit phosphoinositide 3-kinases (PI3K) and useful for the treatment of disorders associated with PI3K enzymes.
US-9,745,307 Compounds that are ERK inhibitors
Disclosed are the ERK inhibitors of formula (I) and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the...
US-9,745,306 2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl)- ...
The present invention relates inter alia to a compound of formula (I) and to compositions comprising the same and to the use of the compounds and to...
US-9,745,305 Modulators of methyl modifying enzymes, compositions and uses thereof
Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.
US-9,745,304 Amidoimidazopyridazines as MKNK-1 kinase inhibitors
The present invention relates to amido-substituted imidazopyridazine compounds of general formula (I): in which A, R1, R2, R3, R4 and n are as defined in the...
US-9,745,303 Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
A method of synthesing a compound of formula (I) from a compound of formula (III). ##STR00001##
US-9,745,302 10H-benzo[g]pteridine-2,4-dione derivatives, method for the production thereof, and use thereof
The invention relates to 10H-benzo[g]pteridine-2,4-dione derivatives, to the production thereof, and to the use thereof.
US-9,745,300 Organic compounds
The invention relates to particular substituted heterocycle fused gamma-carbolines, their prodrugs, in free, solid, pharmaceutically acceptable salt and/or...
US-9,745,299 Substituted tricyclic benzimidazoles as kinase inhibitors
Disclosed are substituted tricyclic benzimidazoles compounds as defined herein in formula (I) or pharmaceutically acceptable salts thereof. The compounds of the...
US-9,745,298 Synthesis of a compound that modulates kinases
The present disclosure provides processes for the preparation of a compound of formula I: ##STR00001## or a salt thereof, active on the receptor protein...
US-9,745,297 Compounds as modulators of RORC
The present invention encompasses compounds of the formula (I), wherein the variables are defined herein which are suitable for the modulation of RORC and the...
US-9,745,296 Salts, co-crystals, and polymorphs of an anxiolytic compound
The present invention provides amorphous arid crystalline forms of 1-ethyl-6-(indan-2-ylamino)-3-(morpholine-4-carbonyl)-1,8-naphthyridin-4-- one (compound 1),...
US-9,745,295 Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
The invention provides certain thiazole-substituted aminoheteroaryl compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein X.sup.1,...
US-9,745,294 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
A compound is represented by Structural Formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a...
US-9,745,293 Sweet flavor modifier
The present invention includes compounds having structural formula (Ia): ##STR00001## or salts or solvates thereof. These compounds are useful as sweet...
US-9,745,292 Compounds, compositions, and methods for increasing CFTR activity
The disclosure encompasses compounds having e.g., Formula (Ia) or (Ib), compositions thereof, and methods of modulating CFTR activity. The disclosure also...
US-9,745,291 PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
Described herein are compounds of Formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present...
US-9,745,290 Dosage regimen for COMT inhibitors
The invention relates to the use of an oxodiazolyl compound (I) for the preparation of a medicament for the prevention or treatment of central and peripheral...
US-9,745,289 Aldosterone synthase inhibitors
The present invention relates to compounds of formula I: ##STR00001## and pharmaceutically acceptable salts thereof, wherein R.sup.1, R.sup.2 and R.sup.3, are...
US-9,745,288 Compounds and methods for treating cancer by inhibiting the urokinase receptor
Compounds and methods for treating or preventing cancer associated with binding to the urokinase receptor are provided. Biological processes affected by the...
US-9,745,287 Pyrimidines and use thereof
The present disclosure provides pyrimidines of Formula I: and pharmaceutically acceptable salts and solvates thereof, wherein A.sup.1, X, A.sup.2, G, Y, n,...
US-9,745,286 Triazole agonists of the APJ receptor
Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the...
US-9,745,285 Heteroaryl substituted pyrazoles
Compounds of formula (I), which are inhibitors of Bub1 kinase, processes for their production and their use as pharmaceuticals. ##STR00001##
US-9,745,284 2-pyridyloxy-4-ether orexin receptor antagonists
The present invention is directed to 2-pyridyloxy-4-ether compounds which are antagonists of orexin receptors. The present invention is also directed to uses of...
US-9,745,283 Uracil derivatives as AXL and c-MET kinase inhibitors
The present application provides compounds of Formula I ##STR00001## or salt forms thereof, wherein R.sub.a, R.sub.b, R.sub.c, R.sub.d, D, W, R.sub.1a,...
US-9,745,282 Indoline compounds as aldosterone synthase inhibitors
This invention relates to indoline compounds of the structural formula: ##STR00001## or their pharmaceutically acceptable salts, wherein the variables are...
US-9,745,281 Method for the synthesis of 4-(heterocycloalkyl)-benzene-1,3,-diol compounds
A method is described for the synthesis of 4-(heterocycloalkyl)-benzene-1,3-diol compounds of general formulae (I) and (II): ##STR00001## wherein X can be an...
US-9,745,280 Compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active...
A compound inhibiting Hsp90 and a pharmaceutical composition including the same as an active ingredient are described, which compound is represented by formula...
US-9,745,279 Sirtuin activator
The present invention provides a sirtuin activator with an active component composed of black ginger or a black ginger extract, which is easily obtainable,...
US-9,745,278 Group of STAT3 pathway inhibitors and cancer stem cell pathway inhibitors
The present invention relates to the use of a novel class of cancer stem cell pathway (CSCP) inhibitors; to methods of using such compounds to treat refractory,...
US-9,745,277 Synthetic process for preparing 2-((2-ethoxy-2-oxoethyl)(methyl)amino)-2-oxoethyl ...
Disclosed herein are processes for forming 2-((2-ethoxy-2-oxoethyl)(methyl)amino)-2-oxoethyl 5-tetradecyloxy)furan-2-carboxylate: ##STR00001##
US-9,745,276 Crystal modifications of elobixibat
The present invention relates to crystal modifications of N-{(2R)-2-[({[3,3-dibutyl-7-(methyl-thio)-1,1-dioxido-5-phenyl-2,3,4,5-te- ...
US-9,745,275 Pain-related compound and medical composition
Provided is a pain-related compound, a pain-related pharmaceutical composition, and use of the same. Provided in one or more embodiments is a compound...
US-9,745,274 Compound, organic cation transporter 3 detection agent, and organic cation transporter 3 activity inhibitor
[Problem] The present invention addresses the problem of providing a novel compound. The present invention also addresses the problem of providing an OCT3...
US-9,745,273 Phenazine derivatives as anti-neoplastic agents and anti-infective agents
Novel phenazine derivatives, methods for their preparation and their medical use, in particular as anti-neoplastic agents and anti-infective agents, are...
US-9,745,272 Quinazoline-2,4(1 H,3H)-dione derivatives
This invention relates to novel Quinazoline-2,4(1H,3H)-dione derivatives of Formula (I): ##STR00001## and their use as TRPC5 modulators, pharmaceutical...
US-9,745,271 5-substituted indazole-3-carboxamides and preparation and use thereof
Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of an indazole...
US-9,745,270 Processes useful for the preparation of ...
The present invention is directed to processes and intermediates useful for the preparation of ...
US-9,745,269 Supercritical fluid extraction of bis-benzyl isoquinolines
An improved process for obtaining at least one bis-benzyl isoquinoline alkaloid from botanical material involves contacting the botanical material with a...
US-9,745,268 Processes and intermediates in the preparation of C5aR antagonists
Intermediates and methods are provided for the preparation of selected C5aR antagonist compounds.
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.